Work

Phase I study of amonafide dosing based on acetylator phenotype.

Year: 1993

Type: article

Study design: Clinical Trial

Source: PubMed

Authors: M J Ratain, R Mick, F Berezin, L Janisch, R L Schilsky, N J Vogelzang, L B Lane

Institution: University of Chicago

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: Cancer Center Support Grant, PHASE I &CLINICAL PHARMACOKINETICS - ANTI-CANCER AGENTS

OpenAlex ID: W2112497968

FWCI: 2.313

Cites: 26

Cited by: 61

Related to: 10